I have a question regarding tumor markers. I just finished chemo TCH(doctaxel, carboplatin and herceptin) stage 2a, node negative, bilat-mastectomy.no lymphovascular invasion and main tumor surrounded by DCIS EIC (at least 25% of all tumor was not invasive by definition) All scans PET negative 7 months ago, brain MRI negative, liver Ultrasound also negative. Did have medication drug induced hepatitis due to levaquin for 45 days in December (chemo caused expander infection and had to be removed) with elevated enzymes (all 3 alp, ast, alt) but have improved within normal range each week during past 6 wks. My CEA was 1.5, ca 15-3 was 5.1 3 months ago, yesterday, day before last chemo basically the same; CEA 1.6 and Ca 15-3 at 6.2. and, todat 3 weeks after last chemo CEA 1.0 and CA 15-3 7.5 (just under one point in 3 weeks and 2.4 points in 4 months. Normal ranges are 2.5 for CEA and 32 for CA 15-3. They are pretty low which is good and my onc said it was ok and not to worry because epithelial tissue also sheds ca 153- so is never zero.My question is if you agree that this little elevation is just a normal variation because is not even 1/4 of Upper normal limit.And if the medication induced hepatitis  can be a factor on this mild raise because hepatitis can also raise ca 15-3? I'm just worried
                                                        
                                                     
                                                    
                                                        
                                                            
                                                            
                                                            
                                                                posted on
                                                            
                                                                Thu, 13 Mar 2014 
                                                            
                                                            
                                                            
                                                            
                                                                
                                                                    
                                                                    
                                                                    Thu, 8 Jun 2017
                                                                    
                                                                    
  Answered on 
                                                                 
                                                                
                                                                    
                                                                    
                                                                    Thu, 8 Jun 2017
                                                                    
                                                                    
  Last reviewed on